Members of the Bcl-2 family play key roles as proapoptotic (e.g., Bax) and antiapoptotic (e.g., Bcl-x L ) regulators of programmed cell death. We previously identified the mitochondrial potassium channel Kv1.3 as a novel target of Bax. Incubating Kv1.3-positive isolated mitochondria with Bax triggered apoptotic events, whereas Kv1.3-deficient mitochondria were resistant to this stimulus. Mutation of Bax at lysine 128 (BaxK128E) abrogated its effects on Kv1.3 and the induction of apoptotic changes in mitochondria. These data indicate a toxin-like action of Bax on Kv1.3 to trigger at least some of the mitochondrial changes typical for apoptosis. To gain insight into the mechanism of Bax-Kv1.3 interaction, we mutated Glu158 of Bcl-x L (corresponding to K128 in Bax) to lysine. This substitution turned Bcl-x L proapoptotic. Transfection of double knockout (Bax À/À /Bak À/À ) mouse embryonic fibroblasts (DKO MEFs) with either wild-type Bax, BaxK128E, or Bcl-x L E158K showed that apoptosis induced by various stimuli was defective in DKO MEFs and BaxK128E-transfected cells, but was recovered upon transfection with Bcl-xLE158K or wild-type Bax. Both wild-type Bax and BaxK128E can form similar ion-conducting pores upon incorporation into planar lipid bilayers. Our results point to a physiologically relevant interaction of Bax with Kv1.3 and further indicate a crucial role of a distinct lysine in determining the proapoptotic character of Bcl2-family proteins.
Mitochondria mediate apoptosis by releasing proapoptotic factors such as cytochrome c, apoptosis-inducing factor (AIF), second mitochondria-derived activator of caspase (Smac/ Diablo), HtrA2, and endonucleases. 1 The release of these factors is the direct consequence of the activation of proapoptotic proteins from the Bcl-2 family, in particular Bax and Bak. Various proteins in the Bcl-2 family are key positive or negative regulators of apoptosis. They share conserved regions called Bcl-2 homology domains (BH1, BH2, and BH3). Biochemical and subcellular fractionation studies localized the antiapoptotic members, such as Bcl-2 and Bcl-x L , at the outer mitochondrial membranes (OMMs) and at the endoplasmic reticulum and nuclear membranes. Proapoptotic factors either reside at the OMM, as is true for Bak, or are cytosolic proteins in unstimulated cells, as is the case for Bax, Bid, and Bad.
Although it is very well known that Bax and Bak are crucial for the induction of apoptosis in many systems, the molecular details of Bax-mediated apoptotic events are still unclear (see, e.g., Antignani and Youle 2 ). A diversity of stimuli have been suggested as initiators of the activation of Bax and Bak, 3, 4 including direct stimulation by BH3-only proteins such as Bid or Bim. 5, 6 Bax activation is believed to be a highly regulated, multistep process involving mitochondrial translocation and oligomerization, and this process ultimately leads to mitochondrial dysfunction and apoptosis. 7, 8 Upon the induction of apoptosis, Bax migrates to the mitochondria, where it is integrated into the outer membrane as a monomer. Bax monomers then oligomerize and may form large pores in the OMM. 8 In its inactive form, Bak is constitutively present in mitochondrial membranes and is released from inhibitory binding partners upon apoptotic stimulation.
Bax and Bid, as well as Bcl-x L and Bcl-2, form pores in synthetic lipid vesicles and membranes. [9] [10] [11] [12] . The ability of Bax to form ion-conducting pores in synthetic and mitochondrial membranes suggests that such pores are involved in the release of cytochrome c. [13] [14] [15] Bax however might work as a twin-arginine translocation (Tat)-like protein rather than as an always-open ion-conducting pore in the OMM. 2 Bcl-2-like proteins have also been shown to interact with some mitochondrial components. Evidence points to interactions between Bax and the machinery involved in mitochondrial fission and fusion (see, e.g., Youle and Karbowski 16 and Scorrano 17 ). Bcl-x L interacts with the adenine nucleotide translocator, an important component of the permeability transition pore complex, and it has been proposed that this interaction prevents cell death. 18 It has also been suggested that Bcl-2 as well as Bax interact with the voltage-dependent anion channel. 19, 20 We have recently shown that OMM-integrated Bax directly interacts with and inhibits an inner membrane-located mitochondrial potassium channel, Kv1.3, 21 in lymphocytes.
22 Kv1 .3 has been shown to be expressed in different tissues and cell types, including brain, lymphocytes, macrophages, liver, and skeletal muscle. 23 The absence of Kv1.3 in lymphocytes prevents Bax-induced release of cytochrome c, as well as changes in mitochondrial membrane potential and the production of reactive oxygen species (ROS). In a previous study we showed that wild-type (WT) Bax inhibits Kv1.3 and induces the release of cytochrome c from isolated mitochondria, whereas Bax with a single-point mutation (K128E) does not induce this effect. 22 According to a model of the structure of the membrane-integrated Bax monomer, at least amino acids 127 and 128, located between the fifth and sixth helices of Bax, protrude from the OMM into the intermembrane space. 8 We determined that Bax binds to the vestibule region of the channel via lysine 128 and preincubation of Bax with recombinant Kv1.3 prevents its proapoptotic effects in isolated mitochondria. 24 The physiological relevance of Kv1.3 for apoptosis was illustrated by the facts that knockdown of Kv1.3 expression in human peripheral blood lymphocytes impaired apoptosis in these cells, and expression of mitochondria-targeted Kv1.3 was sufficient to sensitize apoptosis-resistant CTLL-2T lymphocytes, which lack Kv channels. 22 In this study, we test the function of BaxK128E in a cell system and analyze the mechanism of Bax-Kv1.3 interactions using a mutant of Bcl-x L as a model. We report that mutation of lysine 128 in Bax to glutamate (Glu; Bax K128E) abrogates the proapoptotic function of Bax in a cellular context. The critical role of lysine 128 in Bax for the induction of apoptosis is demonstrated by the finding that exchange of Glu158 of Bcl-x L (corresponding to K128 in Bax) with lysine converts Bcl-x L into a proapoptotic protein.
Human

Mcl-1 Q07820
GRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRT Q6R755 GRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQ ***************************.** ***********.*** Figure 1 Sequence homology between pro-and anti-apoptotic proteins from various species. The T-Coffee algorithm was used for multiple alignments. '*' Indicates identity, ':' indicates conserved, and '.' indicates semiconserved substitutions. (a) Sequence alignment of human antiapoptotic Mcl-1, Bcl-2, and Bcl-x L , as well as that of proapoptotic Bax and Bak. The highly conserved lysine residue in Bax (K128) that is crucial for interaction with Kv1.3 22 is highlighted in light gray. In the corresponding position, Bak contains a glycine; however, adjacent to this G there is a histidine (in light gray). Furthermore, Bak molecules from other species are characterized by an arginine residue in the same position (not shown). The amino acid at position 158 is a highly conserved, negatively charged glutamate (in dark gray) in both Bcl-x L (b) and Bcl-2 (c) from differing species. Accession numbers for sequences from the ExPASy databases are reported
Results
Previous findings
22 demonstrated that Bax requires lysine 128 to induce apoptotic events in isolated mitochondria. The mutation of lysine 128 in Bax prevents the release of cytochrome c and the depolarization of the mitochondrial membrane, events that were observed after the incubation of isolated mitochondria with WT Bax. These findings indicate that the highly conserved positively charged lysine of Bax plugs the pore of the mitochondrial potassium channel Kv1.3, and thereby initiates mitochondrial changes during apoptosis. Antiapoptotic proteins Bcl-2 and Bcl-x L in various species contain a negative charge in the position corresponding to that of K128 in Bax: amino acid (aa) 158 for Bcl-x L (Figure 1 ). In these proteins, a conserved lysine/arginine precedes this glutamate. Thus, whereas in proapoptotic Bcl-2-like proteins an isolated positive charge is found at aa 128, in antiapoptotic Bcl-2-like proteins the positive charge at aa 157 is counterbalanced by a negative charge at position 158, resulting in a net charge of zero in antiapoptotic proteins at this site. The absence of a net positive charge at this site is expected to prevent inhibition of Kv1.3 by the antiapoptotic Bcl-2-like proteins, even if they are in close contact with each other.
On the basis of these considerations, and to gain insight into the mechanism of Kv1.3-Bax interaction, we replaced Glu158 in Bcl-x L with a lysine. Bcl-x L E158K caused a marked inhibition of Kv1.3 in patch-clamp experiments on Jurkat T lymphocytes (Figure 2A ), comparable to that caused by WT Bax ( Figure 2B) Figure 2F ), further supporting a specific interaction of Bax with the pore region of Kv1.3 and the notion that proapoptotic Bcl-2-like proteins mimic the interactions of Kv1.3-inhibiting toxins. 24 To show that mutant Bcl-x L induces changes in mitochondria similar to those induced by WT Bax, we incubated purified Jurkat mitochondria with recombinant GST-Bax (lacking the C-terminal transmembrane domain and therefore able to insert into the membrane 25 ), GST-Bcl-x L , GST-Bcl-x L E158K, or GST as a control. Recombinant GST-Bax and full-length Bax induced very similar effects on isolated mitochondria. 22 Recombinant GST-Bax triggers a hyperpolarization followed by a decrease of the potential of the inner mitochondrial membrane (IMM; Figure 3a) . The electrochemical gradient for K þ predicts that K þ should enter the matrix through a potassium channel located in the IMM. If the influx of K þ becomes inhibited, hyperpolarization is expected. Depolarization, which followed hyperpolarization, was inhibited by cyclosporin A (CSA) and, thus, was probably mediated by the opening of the mitochondrial permeability transition pore (PTP) (see Supplementary Material in Szabó et al. 22 ). The transmembrane potential of Kv1.3-containing Jurkat mitochondria was not altered by incubation with GST alone, GSTBaxK128E, 22 or GST-Bcl-x L (Figure 3a) . In contrast, marked hyperpolarization followed by depolarization was observed when mitochondria were treated with GST-Bcl-x L E158K (Figure 3a) . Likewise, the mutant GST-Bcl-x L E158K, similar to GST-Bax and truncated Bid (tBid)-preactivated full-length Bax (Figure 3b ), triggered a massive release of mitochondrial cytochrome c, whereas GST-Bcl-x L had no effect (Figure 3c ; see Figure 3d for purity control). Importantly, the proapoptotic effects of Bax and GST-Bcl-x L E158K were abrogated in mitochondria isolated from CTLL-2/pJK cells lacking Kv1.3 (Figures 3b and c) . This finding indicates that the Bcl-x L E158K, similar to Bax, exerts its action by regulating Kv1.3 activity in mitochondria isolated from CTLL-2/Kv1.3 cells.
To test the function of the mutant Bcl2-family proteins in intact cells, we transfected mouse embryonic fibroblasts (MEFs) deficient for both Bax and Bak (double knockout (DKO) MEFs) with expression vectors for WT Bax, Bax K128E, or Bcl-x L E158K. Bax/Bak-deficient cells are widely used for determining the effect of mutant Bcl-2 proteins in a cellular context and on isolated mitochondria (see, e.g., Nie et al. 4 and Gavathiotis et al.
5
). The transfection of DKO MEFs with WT Bax or Bcl-x L E158K restored apoptosis induced by staurosporine, etoposide, or sphingomyelinase, whereas transfection with BaxK128E failed to restore apoptosis in these cells (Figures 4a-c) . The cytochrome c release induced by staurosporine in Bax or mutant Bcl-x L E158K-expressing MEF DKO cells was inhibited by CSA (Figure 4d ), suggesting a possible involvement of the PTP in this experimental setup. To avoid a possible proapoptotic effect of protein overexpression per se, the stoichiometry of transfection was adjusted to yield amounts of protein close to those found in untransformed WT cells. The protein levels were determined in the transfected and stimulated cells by western blot and fluorescence-activated cell sorter (FACS; which permits us to determine the expression of Bax in the population also investigated for apoptosis) and were similar to the levels of Bax endogenously expressed by WT MEFs (Figures 4a and b) .
To confirm that Bax interacts with Kv1.3 via lysine 128, we co-transfected Kv1.3 and BaxK128E or WT Bax into MEF DKO cells, induced apoptosis with staurosporine, lysed cells, and determined co-immunoprecipitation of the proteins. The results (Figure 4e ) show that the BaxK128E mutant failed to bind Kv1.3, whereas WT Bax and Kv1.3 interacted after induction of apoptosis.
To exclude that the lack of proapoptotic effects of mutant BaxK128E in DKO MEFs ( Figure 4 ) and in CTLL-2 cells 22 may be caused by alterations of the membrane-insertion capability and/or of the pore-forming properties of Bax by the mutation, we addressed whether the Bcl-2-family proteins used in our studies can efficiently insert into mitochondria. Figure 5a illustrates that mutant recombinant Bax and Bcl-x L are able to insert into MEF DKO-isolated mitochondria as efficiently as the WT recombinant Bax and Bcl-x L , as assayed by alkaline extraction. Activation and oligomerization of Bax can be detected by analyzing resistance of Bax to trypsin. 26 In particular, following these events, amino acids at the N-terminus of Bax become susceptible to trypsin digestion: the rest of the protein is protected, giving rise to truncated Bax of 15 kDa. In our system, in mitochondria isolated from DKO MEF cells, the recombinant Bax WT and Bax mutant equally give rise to such a truncated form (revealed using an antibody against aa 1-171 of Bax (D21)), indicating that the mutated version of Bax is still able to form higher-order oligomers (Figure 5b ). In accordance, BaxK128E is able to induce the release of Smac/Diablo from these mitochondria, similar to Bax WT, whereas the release of cytochrome c is impaired when using mutant Bax (Figure 5c ). Smac/Diablo is released not only from isolated mitochondria using recombinant proteins, but also in MEF DKO cells transfected with mutant Bax (Figure 5d ; see Figure 5e for purity control of cytosolic fraction). Importantly, the effects of recombinant GST-Bax and full-length Bax 22 on isolated mitochondria and those of Bax expressed in MEF cells are the same (Figures 3 and 4) . These results further indicate the ability of Bax and of BaxK128E to form oligomers in the outer membrane and to allow the exit of Smac/Diablo, but also point to another event, that is, inhibition of Kv1.3 by Bax, necessary for the release of cytochrome c. This compulsory proapoptotic event does not take place with BaxK128E (see Figure 4c) , or in the absence of Kv1.3. 22 The notion that interaction of Kv1.3 with Bax is important for the release of cytochrome c but not for the oligomerization of Bax, is further indicated in Figures 6a and b , where in isolated mitochondria, Smac/Diablo and HtrA2/Omi release occurs independently of the presence of Kv1.3 upon incubation with recombinant Bax, suggesting that interaction of the channel with Bax is involved mainly in cytochrome c mobilization rather than in its translocation through the OMM. We tested proapoptotic factor release also in intact CTLL-2/pJK and CTLL-2/Kv1.3 cells challenged with staurosporine. In accordance with data of Figures 3, and 6a and b, cytochrome c is released in a Kv1.3-dependent manner, whereas Smac release occurred also in the absence of the channel. The release of Smac was insensitive to CSA (Figure 6c ). In contrast, the release of AIF and endoG required expression of Kv1.3 and was absent in CTLL-2-pJK treated with staurosporine (Figure 6c ).
Finally, we tested whether recombinant Bax WT and BaxK128E may form channels by incorporating these proteins into planar lipid bilayer. The BaxK128E was able to insert into liposomes and oligomerize as assayed by crosslinking with disuccinimidyl suberate (Figure 7a ). Both WT and mutant Bax proteins formed channels in this system only when added at very high (up to 16 nM; WT: n ¼ 28; mutant: n ¼ 20) concentrations. Although the activities differed, the differences were within the range of the variability displayed by Bax channels from one experiment to the other. Note in Figure 7b that the amplitude of the concentration gradient-driven current passing through the pores at zero applied voltage (the condition believed to prevail at the OMM) and the kinetic behavior (current traces) are similar for the WT and mutant channels. 
Discussion
In this work we provide insights into the mechanisms of action of the proapoptotic Bcl-2-family protein Bax, namely the inhibition of mitochondrial Kv1.3. We also show that an inactive mutant of Bax forms ion-conducting channels similar to those formed by WT Bax, a finding indicating that Bax does not exert its action during apoptosis merely by forming ion-conducting oligomers.
The data obtained with Bcl-x L E158K are consistent with the model we recently proposed for the action of Bax. 22 WT Bax inhibits Kv1.3, a potassium-selective channel of the IMM, and exhibits actions similar to those exerted by margatoxin and charybdotoxin, which block the channel with high specificity. 22 These toxins possess a crucial lysine that blocks the channel by binding to the ring of four aspartate residues of the channel vestibule. Position 128 in Bax, which folds out of the OMM after insertion, 8 corresponds to a highly conserved lysine. If lysine 128 were important for the proapoptotic action of Bax via inhibition of Kv1.3, we expect that introducing a positive charge at the corresponding position in Bcl-x L turns this antiapoptotic protein into a blocker of Kv1.3 with proapoptotic effects. Our results confirm this hypothesis and show that the addition of Bcl-x L E158K to isolated mitochondria efficiently blocks Kv1.3 and induces hyperpolarization and the release of cytochrome c. DKO MEFs were used to verify the effect of these mutations in a cellular context. The fact that mutant Bcl-x L E158K inhibits Kv1.3 and is sufficient to restore cell death in cells lacking Bax and Bak strongly indicates that the crucial lysine residue mediates inhibition of the channel; it may also be important for the physical interaction between Bax and Kv1.3. A single amino acid residue seems to be sufficient to mediate strong protein-protein interactions as previously shown by the observation that, for instance, a point mutation of K27 in agitoxin reduces the affinity of the toxin for the KcsA K þ channel 130-fold. In agreement, data shown in Figure 4e indicate that BaxK128E does not interact with Kv1.3.
The existence of various potassium channels in the IMM of different tissues has been reported (see, e.g., Zoratti et al. 27 and references therein). Mitochondrial potassium channels permit K þ transport into the mitochondrial matrix, regulating thus mitochondrial volume homeostasis, changes in mitochondrial membrane potential, respiration, pH gradient, and synthesis of ROS. 28 In various systems, open potassium channels seem to keep the PTP closed. 29 Kv1.3 was recently found in mitochondria of prostate cancer and breast cancer cell lines PC3 and MCF-7, 24 in hippocampal neurons, 30 and in astrocytes. 29 The observation that the ring of negatively charged amino acids in the pore of potassium channels is structurally highly conserved in all voltage-gated potassium channels (see, e.g., Rauer et al. 31 ) suggests that the action of Bax may not be limited to Kv1.3.
Mutations at K128 in Bax and at E158 in Bcl-x L have not been previously reported, but other point mutations have been shown to alter the activity of Bax and Bcl-x L . Recently, Gavathiotis et al. 5 described a point mutation of Bax (K21E) that identifies a novel structural location of Bax activation. Cysteine 62 of Bax was shown to be critical for its conformational activation and proapoptotic activity in response to H 2 O 2 -induced apoptosis. 4 These results, like ours, point to the importance of a single amino acid for proteinprotein interaction and for the proapoptotic efficiency of Bax. Lysine 128 in Bax and the Glu158 in Bcl-x L are not located within the BH3 domain, making therefore unlikely that these amino acids are involved in the dimerization process of Bax or Bcl-x L . With regard to the possibility that Bax mutations may cause alterations in the release of cytochrome c, Heimlich et al. 32 reported that the Bax-induced release of cytochrome c from mitochondria depends on a-helices 5 and 6, a region comprising K128. However, the effect of these deletions in intact cells has not been investigated. Regarding Bcl-x L , a G138A mutation abrogates the ability of Bcl-x L to dimerize with Bax and prevents the inhibition of cell death induced by deprivation of IL-3 or dexamethasone in the murine prolymphocytic IL-3-dependent cell line F5.12. 33 It should be noted that we mutated Bcl-x L to analyze the role of a critical lysine in Bax for the induction of apoptosis. Our studies demonstrate that a point mutation in Bcl-x L converts the protein into a proapoptotic protein, whereas the mutation of Bax at K128 prevents the induction of apoptosis by Bax. Thus, lysine 128 in Bax plays a crucial role in the induction of apoptosis in a cellular model. The findings further support the notion that Bax induces apoptosis via the direct inhibition of a mitochondrial potassium channel by plugging the pore with K128. We would like to point out that we do not propose Bcl-x L to interact with Kv1.3 in vivo; the Bcl-x L mutant was used as a tool to reinforce the evidence concerning the importance of the lysine residue in Bax.
Recombinant Bax can directly insert into membranes with the a-helices 5 and 6, and it can also spontaneously oligomerize (see, e.g., Antonsson et al. 25 ). In vitro experiments have shown that Bax oligomers are able to conduct cytochrome c. 14, 25, 34 These findings, and the observation that some proteins from the Bcl-2 family form ion-conducting pores Figure 5 Membrane insertion and oligomerization capacity is not altered in BaxK128E. (a) Alkaline extraction does not remove GST-Bax, GST-BaxK128E, GST-Bcl-x L , and GST-Bcl-x L E158K (20 nM each) inserted into mitochondria isolated from DKO MEFs. Mitochondrial fractions and supernatants obtained following centrifugation are shown. Purity of supernatants was assessed using anti-Tom22 antibody. (b) GST-Bax and GST-BaxK128E (20 nM each) were incubated with mitochondria isolated from DKO MEFs and subjected to trypsin treatment where indicated. The N-terminal part is cleaved off as revealed by an antibody against N-terminus (upper panel). GST-Bax (45 kDa) and Bax (22 kDa) are both present in the untreated sample (first lane). Both WT and mutant Bax molecules were protected against complete cleavage as indicated by recognition of the 15 kDa fragment by an antibody against an epitope corresponding to aa 1-171 of Bax (D21). Where indicated, tBid was also added (5 nM) and increased insertion/activation of Bax (middle panel). As a control for the efficiency of trypsinization, the same blot was re-probed with an antibody against Tom22, an outer membrane protein, which is anchored to the cytoplasm-facing side of the membrane only by a short helix (lower panel). (c) Cytochrome c is released from isolated DKO MEF mitochondria by GST-Bax, but to much less extent by GST-BaxK128E, whereas Smac/Diablo is released equally as assessed by stripping and re-blotting of the same membrane with antiSmac antibody. (d) DKO MEF cells were transfected and treated as in Figure 4c and then assessed for released Smac/Diablo content in the supernatant fraction. (e) Mitochondria from DKO MEFs were purified and aliquots of the mitochondrial and cytosolic fractions were blotted with anti-Tom20 or anti-Tim23 antibodies and developed with alkaline phosphatase-coupled secondary antibodies and ECL. The blots reveal the purity of the preparations and show that the cytosolic fractions do not contain the mitochondrial proteins Tom or Tim upon reconstitution in artificial membranes, [10] [11] [12] [13] suggest that cytochrome c may cross the OMM through an aqueous channel formed by assembled Bax monomers, Bak monomers, or hetero-oligomers of both proteins. Our findings do not contradict this hypothesis, but indicate that a Kv1.3-dependent event is necessary for the release of cytochrome c upon the interaction of Bax with mitochondria. Formation of Bax oligomers and pore formation by Bax in the OMM may well occur independently of Kv1.3, as suggested by the release of Smac/Diablo and HtrA2/Omi occurring independently of Kv1.3. On the other hand, the Bax mutant is efficiently inserted and activated in mitochondria ( Figure 5) , and is able to form oligomers and ion channels and mediate the release of Smac/Diablo and HtrA2/Omi ( Figures 5-7) ; yet, cytochrome c is not released with mutant Bax and cell death is impaired (Figure 4) . The notion that Bax itself is not sufficient alone for mediating the efflux of cytochrome c from mitochondria has been also demonstrated by other investigations on the roles of cardiolipin 35 and Opa-1 36 in controlling the release of cytochrome c from mitochondria. Similar to cytochrome c, the release of AIF and EndoG are Kv1.3 dependent (Figure 6 ). AIF and EndoG have been proposed to be released in a ROS-dependent way from mitochondria. 37, 38 Given that Kv1.3 inhibition by Bax leads to an increase in ROS release, 22 one possible explanation for our findings is that Kv1.3 is only involved in ROS-mediated mobilization/release of proapoptotic factors. Further work is required to prove this hypothesis.
Bax and mutant Bcl-x L expressed in MEF DKOs induced a CSA-sensitive cytochrome c release, pointing to a possible involvement of PTP in this process, at least in our experimental setup. CSA may have additional effects in intact cells, and data by Schinzel et al. 39 obtained in cyclophilin-D-less Bax and Bak containing MEFs argue against the involvement of PTP in staurosporine-induced apoptosis. Thus, the role of PTP in MEF death is controversial and further work is required to definitively exclude or prove its role.
In summary, we demonstrate for the first time a single-point mutation in Bcl-x L that converts the protein into a proapoptotic protein, both in experiments with isolated mitochondria and in MEF cells. Our work addresses the mode of action of a singlepoint mutant of Bax in a cellular context, and shows that the Bax mutant loses its ability to mediate cell death. Further work is required to understand how general this feature of Bax action is and to further investigate the role of Kv channels and/ or other potassium channels in general in Bax-mediated apoptosis. 40 Materials and Methods Cell cultures. Jurkat lymphocytes and CTLL-2 cells were grown in RPMI-1640 supplemented with 10% fetal calf serum, 10 mM HEPES (pH 7.4), 2 mM L-glutamine, 1 mM sodium pyruvate, 100 mM nonessential amino acids, 100 units/ ml penicillin, 100 mg/ml streptomycin (all from Life Technologies, Karlsruhe, Germany), and 50 mM b-mercaptoethanol. Mouse interleukin-2 (IL-2) (4 units/ml; Roche Diagnostics, Mannheim, Germany) was added daily to CTLL-2 cells (American Type Culture Collection (ATCC), Manassas, VA, USA). DKO MEFs and control cells (both kindly provided by L Scorrano) were grown in Dulbecco's modified Eagle's medium (DMEM; Gibco, Milan, Italy) supplemented as above (without HEPES). If indicated, we added 2 mM CSA.
Transfections. The lipofectamine technique was used as described by the supplier (Invitrogen, Carlsbad, CA, USA) to co-transfect DKO MEFs with 2 mg/10 7 cells of pJK/ Kv1.3 or pJK plasmids by electroporation and culturing them with 800 mg/ml G418 (Sigma, Deisenhofen, Germany). All experiments except for selection of clones were performed with the bulk cell population. All cultures were re-established from frozen stocks after 4 weeks of growth. Cells were depleted of IL-2 before all experiments to avoid interference by signaling from the IL-2 receptor. To this end, cells were washed in 132 mM NaCl, 20 mM HEPES (pH 7.4), 5 mM KCl, 1 mM CaCl 2 , 0.7 mM MgCl 2 , and 0.8 mM MgSO 4 (H/S) and allowed to recover for 3 h in cell culture medium without IL-2.
Recombinant proteins. Bax (amino acids 1-170) was cloned into pGEX-3X as GST fusion protein, expressed in BL21A1, and purified from bacterial lysates using glutathione-sepharose. Bacteria were lysed in 50 ml of 25 mM HEPES (pH 7.4), 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100, 125 mM NaCl, 10 mM each NaF, Na 3 VO 4 , and sodium pyrophosphate, 10 mM each aprotinin and leupeptin (A/L), and 1 mg/ml lysozyme. Samples were incubated on ice for 15 min so that lysis could be completed, and DNA was degraded with 5 mg/ml DNAaseI in 30 mM MgCl 2 for 30 min. After insoluble material had been pelleted by a 50-min centrifugation at 11 000 Â g at 41C, the GST fusion proteins in the supernatant were immobilized by incubation with 300 ml glutathione sepharose (GE Healthcare, Chalfont St. Giles, UK) for 1 h at 41C. The beads were extensively washed so that any detergents could be eliminated and 20 mM glutathione was added to elute the fusion protein. Glutathione was removed by dialysis and the samples were concentrated to 1 ml by several centrifugation rounds through size-exclusion columns (cutoff, 10 000 Da; Viva Science/Sartorius, Göttingen, Germany). The K128E mutant of Bax and the E158K mutant of Bcl-x L were obtained by a site-directed mutagenesis PCR technique (Stratagene, La Jolla, CA, USA), cloned into pGEX-3X, and expressed and purified as a GST fusion protein as above. In the present study we used a GST-DC-Bax, which lacks the C-terminal transmembrane domain and does not require activation by tBid, for insertion into the membrane and induction of cytochrome c release. 25 Cellular apoptosis assays. To detect the release of mitochondrial cytochrome c and Smac, transfected MEF cells were either left untreated or treated with staurosporine for 12 h, washed in cold HEPES/saline, incubated for 30 min at 41C in 0.3 M sucrose, 10 mM TES (pH 7.4), and 0.5 mM EGTA (TES buffer) and then Dounce-homogenized. Nuclei and unbroken cells were pelleted by centrifugation for 5 min at 600 Â g and 41C. Supernatants were centrifuged at 6000 Â g for 10 min at 41C. The supernatants were used to detect released cytochrome c or Smac/Diablo, and the pellets were used to detect mitochondrial cytochrome c. Proteins were separated on 15% SDS-PAGE, blotted onto a nitrocellulose membrane, and developed with a monoclonal mouse anti-cytochrome c antibody (clone 7H8.2C12; BD Biosciences Pharmingen, San Diego, CA, USA) or with anti-Smac antibody and the Tropix ECL system (Bedford, MA, USA). Morphological signs of apoptosis, such as DNA condensation, nuclear fragmentation, and blebbing, were detected by staining (non-permeabilized) cells with 4 mg/ml propidium iodide and 4 mg/ml ethidium bromide. This method also differentiated apoptotic and necrotic cells. To detect cytochrome c, AIF, Smac, Omi, and EndoG release in intact CTLL-2 cells, the cells were treated with 1 mM staurosporine with or without 2 mM CSA for 12 h. After incubation, the cells were collected, washed with phosphate-buffered saline (PBS), re-suspended in 150 ml of TES buffer, and incubated on ice. Cells were broken with an electric homogenizer (60 s). Unbroken cells were separated by centrifugation at 600 Â g for 10 min at 41C. Mitochondria were separated from cytosol by centrifugation at 7000 Â g at 41C for 10 min. Mitochondria were re-suspended in TES buffer. Both cytosolic fraction and mitochondria were analyzed by western blot.
Alkaline extraction and trypsin treatment. Mitochondria were isolated as described by Szabò et al. 22 1 Â 10 6 DKO MEFs cells/sample were washed with PBS and centrifuged for 10 min at room temperature at 450 Â g. The cells were then re-suspended in 1.5 ml of TES Buffer and incubated in ice for 30 min. After 150 strokes with a glass/teflon potter, intact cells were pelleted by centrifugation for 10 min at 41C at 600 Â g. Mitochondria were separated by centrifugation of the resulting supernatant at 6000 Â g for 10 min at 41C and washed in 500 ml of buffer 1 (50 mM PIPES-KOH (pH 7.4), 50 mM KCl, 2 mM MgCl 2 , constructed from the same experiments and fitted with third order polynomial functions (not shown) indicated that the x axis intercepts are À13 mV for wild type (WT) and À25 mV for mutant Bax; these intercepts correspond to weak cation selectivity (P K /P Cl of 2.7 for wild-type and 7.1 for mutant). The results are representative for at least three independent studies with very similar results 2 mM EGTA, 10 mg/ml A/L, 2 mM ATP, 10 mM phosphocreatine, 5 mM succinate, and 50 mg/ml creatine kinase). Mitochondria were then incubated with GST-Bax, or GST-K128E Bax, or GST-Bcl-X L or GST-E158K Bcl-X L (20 nM each) for 30 min on ice. Na 2 CO 3 (0.1 M final concentration) was added and samples were incubated for further 30 min on ice. Mitochondrial fraction and supernatant were separated by centrifugation at 20 000 Â g for 10 min at 41C. To assess Bax activation/ oligomerization, isolated mitochondria were treated with trypsin (0.51 mg/ml final concentration) for 1.5 h at 301C. Reaction was stopped by addition of equal volume of buffer 1 containing twofold concentrated protease inhibitors. Mitochondrial fraction and supernatant were separated by centrifugation at 20 000 Â g for 10 min at 41C and the former was assayed for the presence of Bax by western blot, using N-20 antibody (Santa Cruz, Santa Cruz, CA, USA) produced against a peptide mapping the N-terminus of Bax or D21 antibody (Santa Cruz) against an epitope corresponding to amino acids 1-171 of Bax.
Cytochrome c and Smac/Diablo release from isolated mitochondria. Mitochondria (obtained from 1 Â 10 6 CTLL-2 or MEF cells) were isolated as described above and were incubated for 30 min on ice in buffer 1 with 5 nM GST-Bax, or 5 nM K128E GST-Bax, or 5 nM GST, or 5 nM tBid, or 15 nM GST-Bcl-2, or 15 nM GST-Bcl-x L , or 15 nM E158K GST-Bcl-x L , or 0.1 nM tBid þ 20 nM full-length Bax (tBid and full length Bax were co-incubated for 15 min at 371C prior to addition to the mitochondria to achieve activation of Bax) so that chimeric proteins could bind to mitochondria. The very low concentration of tBid is sufficient to activate full-length Bax in vitro, but too low to stimulate low amounts of Bax and Bak associating with the outer membrane of isolated mitochondria. The mitochondria were then pelleted and re-suspended in pre-warmed buffer 1 (371C) and incubated for 5 min. The reaction was terminated by the addition of one volume of ice-cold buffer 1, centrifugation at 20 000 Â g at 41C. The supernatants were transferred into new tubes. Reducing SDS sample buffer was added to the supernatants and the pellets. The samples (pellet and supernatant) were analyzed for the release of cytochrome c or Smac/Diablo by western blotting.
Membrane potential in isolated mitochondria. The membrane potential of isolated mitochondria was determined by incubating purified mitochondria from Jurkat cells with 5 nM GST-Bax, or 5 nM GST-BaxK128E, or 5 nM GST, or 5 nM tBid, or 15 nM GST-Bcl-x L , or 15 nM GST-Bcl-x L E158K in buffer 1 supplemented with 10 nM 3,3( 0 )-dihexyloxacarbocyanine iodide (DioC 6 (3)), for 30 min at 41C. Mitochondria were then pelleted and re-suspended in pre-warmed buffer 2 containing 10 nM DioC 6 (3), and the transmembrane potential (Dc m ) was determined by flow cytometry. Hyperpolarization increases the accumulation of DioC 6 (3) in mitochondria, as indicated by a right shift of the fluorescence signal; depolarization is indicated by a left shift. Complete depolarization of mitochondria was achieved by incubation with 1 mM carbonyl cyanide 3-chlorophenylhydrazone (CCCP) for 10 min at room temperature and served as a control for the integrity of the mitochondria. The experiments were repeated with the Dc m indicator tetramethylrhodamine ethyl ester (TMRE) and yielded very similar results.
Flow cytometry studies. To identify cell death in pJK-K158E Baxtransfected cells, the cells were stained with FITC-coupled anti-Myc9E10 antibodies to detect the Myc-epitope present on the single chain antibody, which is also encoded by the pJK vector. Death was detected by staining with Cy3-labelled Annexin. Samples were analyzed using FACS-Calibur (Becton-Dickinson, Franklin Lakes, NJ, USA).
